J 35 Pill - white capsule/oblong, 12mm
Pill with imprint J 35 is White, Capsule/Oblong and has been identified as Tenofovir Disoproxil Fumarate 150 mg. It is supplied by Aurobindo Pharma Limited.
Tenofovir is used in the treatment of Hepatitis B; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tenofovir 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for J 35
Tenofovir Disoproxil Fumarate
- Imprint
- J 35
- Strength
- 150 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 65862-0818
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch,
hypromellose 2910 (15 mPa.s),
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "J 35"
More about tenofovir
- Check interactions
- Compare alternatives
- Reviews (25)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
- Tenofovir drug information
- Tenofovir (Advanced Reading)
- Tenofovir Disoproxil Fumarate Tablets
- Tenofovir Disoproxil Fumarate Oral Powder
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
